Sabine Naxer

Sabine Naxer

Auto-generated profile, based on publicly available information

Sabine Naxer

Department of Ophthalmology, University Medical Center Göttingen, Goettingen, Germany

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 August 2018 in Strabismus
Verified
Journal Article
Closed access
SNSabine Naxer
Sabine Naxer
MHMaren Horn
Maren Horn
MSMichael Schittkowski
Michael Schittkowski
Introduction: In ophthalmology amniotic membrane is usually used for the treatment of corneal ulcerations and chemical burns of the ocular surface. Also, it is useful in the treatment of conjunctival defects. There are few publications on the long-term outcomes with the use of amniotic membrane to replace the conjunctiva. In our cases, we used it in patients with restrictive strabismus or conjunctival problems during or following complex eye muscle surgery. Materials and methods: In this retrospective case study, we reviewed the charts of the patients who had been treated with Ambio5® (IOP Inc. USA) for the replacement of conjunctiva in the treatment of conjunctival problems during or following complex eye muscle surgeries in our ophthalmology department between 2009 and 2015. Ambio5® is a processed dry, multi-layered amniotic membrane of 110-micron thickness. Inclusion criteria were the use of it in the treatment of conjunctival problems during or following complex eye muscle surgery. Results: Thirty-two patients were identified. Among the 32 identified patients, 7 patients (6 female, 1 male) had restrictive conjunctiva following complex strabismus surgery with functional problems or aesthetic conjunctival scarring requiring transplantation. The mean age of these patients was 47 years (range: 22–60 years). Mean follow-up time was 32 months (range 18–55 months). Only one of these seven patients suffered a discomfort related to conjunctival scarring. The other six patients had restrictive strabismus, four of them suffered from Graves’ ophthalmopathy. All patients improved although three patients developed symblepharon. One of these patients needed revision because of a symblepharon. Discussion: The result of our study indicates that commercially prepared amniotic membrane is a good alternative graft to replace conjunctiva. It helps to prevent or cure restrictive strabismus, scarring of the conjunctiva with discomfort, and lack of conjunctiva. It is possible that commercially storable products may increase the risk of symblepharon, the reason is unknown.

19 August 2010 in Klinische Monatsblätter für Augenheilkunde
Verified
Journal Article
Closed access
SNS. Naxer
S. Naxer
CBC. L. Behnes
C. L. Behnes
MSM. P. Schittkowski
M. P. Schittkowski
Hintergrund: Eine Amyloidose wird durch fehlgefaltete Proteine verursacht. Diese Proteine lagern sich in Geweben und Organen ab und können dadurch Funktionen beeinträchtigen. Material und Methoden: Es werden 2 Patienten vorgestellt und eine Übersicht über die bislang in der Literatur veröffentlichten rein orbitalen lokalisierten Fälle dargestellt. Ergebnisse: Der erste Fall ist eine 50-jährige Patientin mit einer seit einem halben Jahr zunehmender Ptosis, einem seit 3 Monaten zunehmenden Exophthalmus und einer Motilitätseinschränkung mit Bulbusdeviation des linken Auges. Der zweite Fall ist ein 68-jähriger Patient mit einer seit 4 Jahren zunehmenden Ptosis und Beteiligung der subtarsalen Bindehaut des rechten Auges. Intraoperativ zeigte sich makroskopisch jeweils ein gelb-bräunliches gallertartiges, leicht bröckliges Material. Schlussfolgerung: Der histologische Nachweis der Amyloidse gelingt mit der Polarisationslichtmikroskopie nach Anfärbung mit Kongorot, die bei Verdacht immer durchgeführt werden sollte. Da im Rahmen einer systemischen Form der Amyloidose die Orbita ebenfalls betroffen sein kann, sollte dies internistisch ausgeschlossen werden. Die lokalisierte orbitale Amyloidose hat im Gegensatz zu den systemischen Formen keinen Einfluss auf die Überlebenszeit. Eine unbehandelte systemische Amyloidose kann jedoch teilweise eine Prognose von nur 9 – 13 Monaten haben. Background: Amyloidosis is a disorder caused by a misfoulding of proteins. The deposition of these proteins in tissues and organs can affect the normal function of those tissues and organs. Materials and Methods: Two patients are presented and an overview over the so far published cases with a localised orbital amyloidosis is given. Results: The first case is a 50-year-old woman with progressive ptosis since half a year, progressive proptosis since three months and deterioration of motility and deviation of the left globe. The second case is a 68-year-old man with progressive ptosis since four years and with affection of the subtarsal conjunctiva of the right eye. Macroscopically a yellow-brown, gelatinous, easily crumbled material was seen during operation. Conclusion: the histological proof of amyloidosis can be made visually in intense unidirectional polarised light after congo red staining. This should be done in suspected cases every time. The orbita can also be involved in systemic forms of amyloidosis, so a systemic form should be excluded. The localised amyloidosis has no effect on the survival time in contrast to the systemic forms does have an effect. An untreated systemic form may be associuated with a prognosis of only 9 to 13 months.

30 September 2022 in Strabismus
Verified
Journal Article
Closed access
MEMohamed Elabbasy
Mohamed Elabbasy
SNSabine Naxer
Sabine Naxer
MHMaren Horn
Maren Horn
MSMichael P. Schittkowski
Michael P. Schittkowski
To study the secondary management of strabismus due to third nerve palsy using bovine pericardium (Tutopatch®) when previous conventional surgical therapy had failed. Review of our clinic records of selected patients with third nerve palsy, in whom residual deviation had been managed using Tutopatch® after previous surgical correction. The squint angle was measured preoperatively, and at 1 day, 3 months, and if possible 6 months postoperatively. Nine patients were enrolled in this study. One patient had mainly residual vertical deviation and was corrected with tendon elongation of the contralateral superior rectus. Three patients were operated on with tendon elongation of the lateral rectus muscle with or without medial rectus muscle resection and/or advancement (Group 1). Lateral rectus splitting after tendon elongation in addition to the resection and/or advancement of the medial rectus was performed in five patients with complete third nerve palsy (Group 2). In Group 1, the preoperative median squint angle was −20° (range −17° to −25°), which improved postoperatively to −4.5° (range −12° to +3°). In Group 2, the preoperative horizontal and vertical median squint angles were −27° (range −20° to −40°) and 0.5° (range 0° and 20°), respectively. Postoperatively, they had improved to −12.5° (range–2° to −25°), and 1.5° (range 0° to 7°), respectively. Two patients of Group 2 were re-operated due to residual exotropia. No postoperative complications were observed in any patient. In this small series several complex re-do situations of patients with third nerve palsy were evaluated in which Tutopatch® markedly improved outcomes after an initially ineffective surgical management. For better evaluation of its usefulness a study with more patients is recommended.

21 March 2023 in Children
Verified
Journal Article
Open access
PDF file
MSMichael P. Schittkowski
Michael P. Schittkowski
SNSabine Naxer
Sabine Naxer
MEMohamed Elabbasy
Mohamed Elabbasy
LHLeonie Herholz
Leonie Herholz
VBVivian Breitling
Vivian Breitling
LSLars Schlotawa
Lars Schlotawa
Multiple sulfatase deficiency (MSD) is an extremely rare autosomal recessively inherited disease with a prevalence of 1:500.000 caused by mutations on the sulfatase-modifying-Factor 1 gene (SUMF1). MSD is most specifically characterised by a combination of developmentally retarded psychomotoric functions, neurodegeneration that entails the loss of many already acquired abilities, and by ichthyosis. Other symptoms include those associated with mucopolysaccharidosis, i.e., facial dysmorphy, dwarfism, and hepatosplenomegaly. In 50–75% of all MSD-affected patients, functional or structural ocular damage is likely. MSD seldom affects the anterior segment of the eye. The main pathology these patients present is a highly conspicuous tapetoretinal degeneration, similar to severe Retinitis pigmentosa, that leads to blindness at an early age. An initially five-year-old boy with MSD, genetically verified at his first examination in our opthalmology department (SUMF1 mutations c.776A>T, p.Asn259Ile; c.797A>T, p.Pro266Leu; c.836A>T, p.Ala279Val), and a 4, 5 year regular follow-up are described. The patient had some visual potential (“tunnel view”), which deteriorated dramatically after his fifth birthday. We observed no evidence of worsening retinal involvement in this patient in spite of his progressively worsening clinical symptoms, extending to total blindness/no light perception. OCT revealed that the outer retinal layers containing photoreceptors were diseased; the ellipsoid zone was only partially discernible and the outer nuclear layer appeared to be thinned out. The inner nuclear layer, ganglion cell layer, and retinal nerve fibre layer were indistinguishable. These anomalies are indicative of a severe pathology within the retina’s inner layers. Characteristic anomalies in the fundus should stimulate clinicians to suspect a case of MSD in their differential diagnosis, and thus to order thorough genetic and paediatric diagnostics.

23 July 2012 in Klinische Monatsblätter für Augenheilkunde
Verified
Journal Article
Closed access
MSMichael P. Schittkowski
Michael P. Schittkowski
SNS. Naxer
S. Naxer
Hintergrund: Über die Anwendung von Fadenoperationen außerhalb der Indikation Innenschielen liegt vergleichsweise wenig Literatur vor. Patienten und Methoden: Retrospektive Auswertung der verfügbaren Daten der Patienten, bei denen eine andere Indikation als Innenschielen zur Fadenoperation geführt hatte, bei denen zwischen 2000 und 2011 eine oder mehrere Fadenoperationen ausgeführt wurden und bei denen eine Nachkontrolle mindestens 3–6 Monate postoperativ erfolgt war. Insgesamt konnten 23 Patienten identifiziert werden, davon 9 mit endokriner Orbitopathie (EO), 9 mit Okulomotoriusparesen sowie 3 Patienten mit Abduzensparese und Diplopie im Seitblick, 1 Patient mit okulopharyngealer Muskeldystrophie und je 1 Patient mit Senkungsdefizit respektive Hebungsdefizit nach Orbitatrauma. Ergebnisse: Von 7 horizontal betroffenen Patienten (4 mit EO, 3 mit Abduzensparese) wurden 5 Patienten einseitig und 2 Patienten beidseitig operiert. Das horizontale Ausmaß des BES-Feldes lag präoperativ zwischen 15° und 70° (Mittel 44,3°) und konnte bei den einseitigen Operationen um minimal 10° bis maximal 25° (Mittel 16,9°) und bei den beiden beidseitigen Operationen um 20° bzw. 35° auf 30–80° (Mittel 55,6°) vergrößert werden. Von 16 vertikal betroffenen Patienten (alle 8 mit Okulomotoriusparese, 5 mit EO, 2 nach Orbitatrauma, 1 mit Muskeldystrophie) wurde nur 1 Patientin gleichzeitig am Rectus superior und inferior operiert, bei allen anderen wurde nur eine Fadenfixation vorgenommen. Das vertikale Ausmaß des BES-Feldes lag präoperativ zwischen 5° und 55° (Mittel 31,2°) und konnte bei den einseitigen Operationen um minimal 5° bis maximal 45° (Mittel 19,7°) und bei der einen gleichzeitig am Rectus superior und inferior durchgeführten Operation um 20° auf 10–80° (Mittel 49,2°) gesteigert werden. Schlussfolgerungen: Fadenoperationen können wirkungsvoll zu einer Entfaltung des Feldes binokularen Einfachsehens beitragen. Das potenzielle Risiko einer Verschlechterung der Situation mit Verstärkung der Diplopiewahrnehmung erscheint gering; es bleibt aber in jedem Fall zu bedenken, und der Patient ist darüber aufzuklären. Eine Dosis-Wirkungs-Beziehung anzugeben erscheint nicht möglich. Background: Faden operations is a well-known surgical option for the treatment of esotropia. To the best of our knowledge there are only a few reports available dealing with this particular topic. Patients and Method: Retrospective series of patients in whom between 2000 and 2011 a faden operation was performed under all indications except esotropia. 23 patients (9 Gravesʼ disease, 9 third nerve palsy, 3 sixth nerve palsy, 1 muscle dystrophy, 2 orbital trauma) were included. Results: 5 out of 7 horizontally disturbed patients were operated unilaterally and the remaining 2 bilaterally. The field of binocular single vision increased from 15–70° preoperatively by 10–25° (unilateral) and 20–35° (bilateral) to 30–80° postoperatively. Out of the 16 vertically disturbed patients only one was operated on superior and inferior rectus simultaneously and all the other on only one muscle. The field of binocular single vision increased from 5–55° preoperatively by 5–45° to 10–80° postoperatively. There were no complications so far and none of the patients worsened with the surgery. Conclusion: A faden operation might help to increase the field of binocular single vision in cases of restrictive squint like Gravesʼ disease or in paralytic strabismus.

22 July 2025 in British Journal of Ophthalmology
Verified
Journal Article
Closed access
PDF file
NCNike Annika Christensen
Nike Annika Christensen
NFNicolas Feltgen
Nicolas Feltgen
MHMaren Horn
Maren Horn
SNSabine Naxer
Sabine Naxer
COChristian van Oterendorp
Christian van Oterendorp
MSMichael P. Schittkowski
Michael P. Schittkowski
Background/Aims Clear guidelines for managing patients on antiplatelet (AP) or anticoagulant (AC) therapy undergoing oculoplastic surgery are lacking. This study investigates bleeding risk factors and evaluates the effectiveness of a standardised bleeding risk assessment in extraocular surgery. Methods In this prospective study, a standardised questionnaire (SQ) was employed to gather patients’ bleeding histories. Associations between SQ scores and preoperative/demographic factors (AP/AC use, age, sex, comorbidities), and surgical factors (blood pressure, surgery type, primary vs revision surgery, anaesthesia type, duration, pain management) were assessed. A scoring system quantified bleeding severity. Patients were monitored postoperatively for 24 hours (eyelid procedures) to 3 or 4 days (orbital/nasolacrimal surgery). Results A total of 324 patients (aged 18–92) were included (252 eyelid, 56 orbital and 16 nasolacrimal surgeries). 87 patients were using AP, AC and/or herbal supplements. Severe bleeding occurred in 35 patients, four required revision surgery, though none suffered permanent damage. Bleeding complications were significantly associated with higher SQ scores (p=0.048), acetylsalicylic acid use in eyelid surgery (p=0.038), diabetes mellitus (p=0.016), renal disease (p=0.044), general anaesthesia (p=0.001) and longer surgery duration (p=0.007). Local anaesthesia, AC use and systolic hypertension were not significantly associated with bleeding risk. Conclusion The SQ is a valuable tool for assessing bleeding risk in oculoplastic patients. Findings support future multicentre studies to develop evidence-based perioperative guidelines for AP and AC management. Limitations include cohort heterogeneity, small sample size, non-blinded design and subjective bleeding scores affecting comparability.